brain–computer interfaces — Shanghai moves to advance standards and speed vaccine batch releaseChina Hardware China Software Tech in ChinaMedical Devices, No Company Names Identified, Pharmaceuticals, regulation November 27, 2025
Quick snapshot — What the measures coverChina Hardware China SoftwareBrain-Computer Interfaces, Cell and Gene Therapies, Medical Devices, Pharmaceuticals November 27, 2025
CAR‑T therapies could break through in this year’s commercial‑insurance price talksChina Finance Tech in ChinaCAR-T, Healthcare, Heyuan Shengwu, Medical Insurance, National Healthcare Security Administration, Pharmaceuticals November 4, 2025
CAR‑T therapies: “Sky‑high” CAR‑T Cancer Therapies Could Break Through in This Year’s Commercial‑Insurance Price NegotiationsChina Finance China StartupsCailian Press, Healthcare, Heyuan Shengwu, NHSA, Pharmaceuticals November 3, 2025
Fosun Pharma’s Q1–Q3 2025 results: clear growth in innovative drugs and a planned vaccine spin‑offChina Finance China Startups Tech in ChinaFosun Pharma, Fuxing Antejin, Healthcare, Pharmaceuticals October 29, 2025
US$11.4 Billion Deal: Innovent Biologics (Xìn Dá Shēng Wù 信达生物, 01801.HK) and Takeda (Wǔ Tián Zhì Yào 武田制药) Announce Global BD Collaboration to Co‑develop Three Oncology CandidatesChina Finance China StartupsHealthcare, Innovent Biologics, Oncology, Pharmaceuticals, Takeda October 22, 2025
U.S. Draft Executive Order “More Bark Than Bite”: Will Chinese Innovative-Drug BD Deals Still Benefit Long-Term?China Finance Tech in China3SBio, Biotech, CSPC Pharmaceutical Group, FDA, GSK, Hebo Pharmaceuticals, Hengrui, Pharmaceuticals September 12, 2025
China’s Star Fund Managers Are Piling Into Pharma. Here’s Their 2025 Playbook.China Finance China SoftwareBYD, Fu Pengbo, Gao Nan, Investment Trends, Pharmaceuticals, Tencent July 20, 2025
China Unveils a Game-Changing Policy for Innovative Drugs: Here’s What Investors Need to KnowChina Finance Tech in ChinaBiotech, Healthcare, Hotgen Biotech, Pharmaceuticals, policy, RemeGen, Shutaishen, Sino Biopharmaceutical, Yifan Pharmaceutical July 1, 2025
China’s Innovative Drug Sector is Exploding: Here’s Why Investors Are BuzzingChina Finance Tech in China3SBio, Biotechnology, Bohai Securities, Changshan Pharma, China Securities, Cinda Securities, CSPC Pharmaceutical Group, Everbright Securities, Haichen Pharmaceutical, Healthcare, Huafu Securities, Innovative Drugs, Joincare Pharmaceutical, Lianhe Chemical Technology, Luoxin Pharmaceutical, Medicilon, NMPA, Pfizer, Pharmaceuticals, Shenyang Sansheng, Sunshine Guojian, Xiangcai Securities June 9, 2025
Innovent Biologics (Xìndá Shēngwù 信达生物) Stock Jumps 18% on Promising IBI363 Lung Cancer Data, Igniting the Innovative Drug SectorChina Finance3SBio, Biotech, CSPC Pharmaceutical Group, Innovation, Innovent Biologics, Pharmaceuticals June 4, 2025
